Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...
A empresa farmacêutica dinamarquesa Novo Nordisk tem ganhado destaque global devido ao sucesso de seus medicamentos para ...
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
Presidente Lula pode voltar ao estado para participar do anúncio de investimentos da indústria farmacêutica dinamarquesa Novo Nordisk; saiba os detalhes ...
Novo Nordisk to Pay $2 Billion for New Weight Loss Drug TUESDAY, March 25, 2025 (HealthDay News) -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 ...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...
The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo ...
Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also underperformed in the sector and the S&P 500 during the same time ...
Novo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal worth up to $2bn as the Wegovy (semalgutide) developer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback